Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration.
Aki KatoTsutomu YasukawaIichiro SugitaMunenori YoshidaMiho NozakiYoshio HiranoJunko KondoTomohiro AbeKimiko SugitaTakahide OkitaHiroshi MoritaNoriaki TakaseYuichiro OguraPublished in: Advances in therapy (2022)
This clinical study was registered retrospectively on December 22, 2014 with the ClinicalTrials.gov identifier NCT02321839.